COVID-Protected pathways for image guided lung cancer intervention during the COVID-19 pandemic: A cohort study
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Objectives:To compare the experience of COVID-protected and mixed cohort pathways in COVID-19 transmission at a tertiary referral hospital for elective CT-guided lung biopsy and ablation during the COVID-19 pandemic.
Methods:From September 2020 to August 2021 patients admitted for elective thoracic intervention were treated at a tertiary hospital (Site 1). Site one received patients for extracorporeal membrane oxygenation (ECMO) and invasive ventilation in the treatment of COVID-19. Shared imaging, theatre, and hallway facilities were used.From April 2020 to August 2020 patients admitted for elective thoracic intervention were treated at a COVID-protected hospital (Site 2). No patients with suspected or confirmed COVID-19 were treated at Site 2.Patients were surveyed for clinical and laboratory signs of COVID-19 infection up to 30 days post-procedure.
Results:At Site 1, 2 patients (2.4%) tested positive for COVID-19 at 10 and 14 days post-procedure.At Site two there were no COVID-19 positive cases within 30 days of undergoing elective thoracic intervention.
Conclusion:A mixed-site method for infection control could represent a pragmatic approach to the management of elective procedures during the COVID-19 pandemic or for similar illnesses.
Advances in knowledge:Mixed-cohort infection control is possible in the prevention of nosocomial COVID-19 infection.
The British Journal of Radiology , article en libre accès, 2021